Sex-specific mechanisms in vascular aging: exploring cellular and molecular pathways in the pathogenesis of age-related cardiovascular and cerebrovascular diseases
GeroScience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 3, 2025
Language: Английский
Deep learning and generative artificial intelligence in aging research and healthy longevity medicine
Aging,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 16, 2025
With
the
global
population
aging
at
an
unprecedented
rate,
there
is
a
need
to
extend
healthy
productive
life
span.
This
review
examines
how
Deep
Learning
(DL)
and
Generative
Artificial
Intelligence
(GenAI)
are
used
in
biomarker
discovery,
deep
clock
development,
geroprotector
identification
generation
of
dual-purpose
therapeutics
targeting
disease.
The
paper
explores
emergence
multimodal,
multitasking
research
systems
highlighting
promising
future
directions
for
GenAI
human
animal
research,
as
well
clinical
application
longevity
medicine.
Language: Английский
Mikhail ‘Misha’ Blagosklonny’s enduring legacy in geroscience: the hyperfunction theory and the therapeutic potential of rapamycin
David Barzilai
No information about this author
Aging,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 12, 2025
The
untimely
passing
of
Dr.
Mikhail
"Misha"
Blagosklonny
has
left
a
lasting
void
in
geroscience
and
oncology.
This
review
examines
his
profound
contributions,
focusing
on
pioneering
the
Hyperfunction
Theory
advocacy
for
rapamycin,
an
mTOR
inhibitor,
as
therapeutic
agent
lifespan
extension.
Contrary
to
traditional
damage-centric
models,
rejects
damage
accumulation
primary
driver
aging.
Instead,
it
redefines
aging
quasi-programmed
process
driven
by
persistent,
excessive
activity
growth-promoting
pathways
beyond
their
developmental
roles,
leading
age-related
pathologies.
We
explore
how
Blagosklonny's
insights
predict
rapamycin's
ability
decelerate
modulating
signaling,
supported
empirical
evidence
across
multiple
physiological
systems,
including
immune,
cardiovascular,
cognitive,
oncologic
health.
His
forward-thinking
approach,
advocating
cautious
clinical
use
rapamycin
suggesting
personalized,
preventive,
combination
therapy
strategies,
catalyzed
interest
translational
geroscience.
synthesizes
legacy,
presenting
foundational
pharmacological
intervention
with
potential
managing
decline
extending
healthspan,
underlines
impact
shifting
research
from
theoretical
frameworks
actionable
interventions.
work
remains
enduring
inspiration,
paving
way
toward
treating
modifiable
condition.
Language: Английский
From geroscience to precision geromedicine: Understanding and managing aging
Cell,
Journal Year:
2025,
Volume and Issue:
188(8), P. 2043 - 2062
Published: April 1, 2025
Language: Английский
Towards Precision Geromedicine in Singapore
Jonas John Posko Amalaraj,
No information about this author
Louis Island,
No information about this author
Jane Yu Ying Ong
No information about this author
et al.
GeroScience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 8, 2025
Language: Английский
Gerogenes and gerosuppression: the pillars of precision geromedicine
Cell Research,
Journal Year:
2024,
Volume and Issue:
34(7), P. 463 - 466
Published: May 27, 2024
Language: Английский
A Framework for an Effective Healthy Longevity Clinic
Mironov Sp,
No information about this author
Olga Borysova,
No information about this author
Ivan Morgunov
No information about this author
et al.
Aging and Disease,
Journal Year:
2024,
Volume and Issue:
unknown, P. 0 - 0
Published: Jan. 1, 2024
In
the
context
of
an
aging
global
population
and
imperative
for
innovative
healthcare
solutions,
concept
longevity
clinics
emerges
as
a
timely
vital
area
exploration.
Unlike
traditional
medical
facilities,
offer
unique
approach
to
preclinical
prevention,
focusing
on
"prevention
prevention"
through
utilization
clocks
biomarkers
from
healthy
individuals.
This
article
presents
comprehensive
overview
clinics,
encompassing
descriptions
existing
models,
development
proposed
framework,
insights
into
biomarkers,
wearable
devices,
therapeutic
interventions.
Additionally,
economic
justifications
investing
in
are
examined,
highlighting
significant
growth
potential
biotechnology
market
its
alignment
with
goals
achieving
active
longevity.
Anchored
by
Analytical
Center,
framework
underscores
importance
data-driven
decision-making
innovation
promoting
prolonged
enhanced
human
life.
At
present,
there
is
no
universally
accepted
standard
model
clinics.
absence
highlights
need
additional
research
ongoing
improvements
this
field.
Through
synthesis
scientific
practical
considerations,
aims
stimulate
further
discussion
field
ultimately
contributing
advancement
practices
aimed
at
extending
enhancing
Language: Английский